Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
10 June 2019 | Story Ruan Bruwer | Photo Gerda Steyn Twitter
Gerda Steyn
Gerda Steyn, a former student at the University of the Free State, won her first Comrades race on Sunday, setting a new course record.
Winning the Comrades ultra-marathon is the greatest honour of her life and still feels unreal, said Gerda Steyn a day after winning the race in a record time.
 
The former Kovsie student had an incredible race on Sunday, completing the 86,83 km’s in a time of 05:58:54, which is a new record for women in the up run. It is more than 10 minutes faster than the previous record of 06:09:23 set in 2006.
 
It was also the fourth fastest Comrades time ever by a female in the 94-year history of the race.
 
Greatest honour of my life
 
“Being the Comrades winner is the greatest honour of my life. Thank you to an entire nation for carrying me to the line. It feels like a dream,” Steyn said.
 
The 29-year-old Steyn became the first woman in 30 years to win both the Comrades and Two Oceans in the same year. She also won the Two Oceans in 2018 and came second in the Comrades last year.
 
Steyn, who studied Quantity Surveying and Construction Management at the University of the Free State (UFS) between 2009 and 2012, said the record time was discussed beforehand.
 
I went for it
 
“We felt it was possible, but it wasn’t my main goal right from the start of the race. At the halfway mark, I saw it was possible and I went for it.”
 
According to Steyn, the media attention since her win is quite intense. “But I don’t complain. It is such an honour, so I do it with a smile.”
 
At the Two Oceans ultra-marathon in April, she missed out on the 30-year record time by just 53 seconds.
 
Prof Francis Petersen, UFS Rector and Vice-Chancellor, said Steyn was a proud ambassador of the university. “It is always important for me to see how our former students perform. I would like to congratulate her. Well done. She is carrying the Kovsie name with pride,” Prof Petersen said.
 

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept